Evidence map›Paper›PMID 21927805›Full record

ReviewCurrent psychiatry reports2011

Is depression an inflammatory disorder?

Charles L Raison, Andrew H Miller

Registry-linked trialAbstract readReview
In one paragraph

Review in Current psychiatry reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03143075 (Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?), which is not on this map. Cited by 237 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
237citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03143075 nacompletednot on this mapstarted 2017, after this paper: background citation

Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?

TypeinterventionalSponsorRegion SkaneRan2017 to 2023Enrolled95ConditionsMajor Depressive DisorderArmsEicosapentaenoic acid enriched omega-3 fatty acids, 2 g/day
3 · Its place in the literature

Who cites it

237 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. 5-HTCurrent neuropharmacology · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Omega-3 fatty acids reduce depressive symptoms only among the socially stressed: A corollary of the social signal transduction theory of depression.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2023
    Trial
  7. Circulating versus lipopolysaccharide-induced inflammatory markers as correlates of subthreshold depressive symptoms in older adults.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2020
    Trial
  8. Trial
  9. Trial
  10. Acetyl-l-carnitine deficiency in patients with major depressive disorder.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Trial
  11. Trial
  12. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Charles L RaisonDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1365C Clifton Road, Fifth Floor, Atlanta, GA 30322, USA. craison@emory.edu
Andrew H Miller

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2010 to 2014
$2.2M
Dopaminergic Mechanisms of Cytokine-Induced Behavioral ChangeR01MH083746 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2009 to 2012
$1.5M
Neuroimmune Mechanisms of Glucocorticoid ResistanceR01MH075102 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2006 to 2010
$1.0M
NCATS NIH HHS UL1 TR000454NIMH NIH HHS R01 MH075102NIMH NIH HHS R01 MH083746NIMH NIH HHS R01 MH087604
6 · The paper itself

Abstract

Studies consistently report that groups of individuals with major depressive disorder (MDD) demonstrate increased levels of a variety of peripheral inflammatory biomarkers when compared with groups of nondepressed individuals. These findings are often interpreted as meaning that MDD, even in medically healthy individuals, may be an inflammatory condition. In this article, we examine evidence for and against this idea by looking more closely into what the actual patterns of inflammatory findings indicate in terms of the relationship between MDD and the immune system. Data are presented in support of the idea that inflammation only contributes to depression in a subset of patients versus the possibility that the depressogenic effect of inflammatory activation is more widespread and varies depending on the degree of vulnerability any given individual evinces in interconnected physiologic systems known to be implicated in the etiology of MDD. Finally, the treatment implications of these various possibilities are discussed.

Indexed as

Anti-Inflammatory AgentsAutonomic Nervous SystemBiomarkersCytokinesHumansInflammationMajor Depressive DisorderStress, PsychologicalAnti-Inflammatory AgentsBiomarkersCytokines

Identifiers

PMID21927805
PMCPMC3285451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.